WallStSmart

Cambium Networks Corp (CMBM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 50% more annual revenue ($258.90M vs $172.22M). ZEPP leads profitability with a -15.5% profit margin vs -57.0%. CMBM earns a higher WallStSmart Score of 53/100 (C-).

CMBM

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 2.0Value: 6.7Quality: 3.5
Piotroski: 3/9Altman Z: 0.39

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CMBM.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CMBM3 strengths · Avg: 10.0/10
PEG RatioValuation
0.3410/10

Growing faster than its price suggests

Price/BookValuation
0.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
569.0%10/10

Earnings expanding 569.0% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

CMBM4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

Market CapQuality
$49.99M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.763/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : CMBM

The strongest argument for CMBM centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.34 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : CMBM

The primary concerns for CMBM are Revenue Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.76 is elevated, increasing financial risk.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

CMBM profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

CMBM carries more volatility with a beta of 2.00 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CMBM scores higher overall (53/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cambium Networks Corp

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Cambium Networks Corporation provides wireless broadband network infrastructure products and solutions for network operators. The company is headquartered in Rolling Meadows, Illinois.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?